Hendlisz A - Search Results

1

A therapeutic approach to perianal extramammary Paget's disease: topical imiquimod can be useful to prevent or defer surgery.

Vereecken P, Awada A, Ghanem G, Marques da Costa C, Larsimont D, Simoens C, Mendes da Costa P, Hendlisz A. Vereecken P, et al. Among authors: hendlisz a. Med Sci Monit. 2007 Jun;13(6):CS75-7. Med Sci Monit. 2007. PMID: 17534239

2

Immunotherapies in non-metastatic gastrointestinal cancers.

Saúde-Conde R, Nguyen D, Hendlisz A. Saúde-Conde R, et al. Among authors: hendlisz a. Curr Opin Oncol. 2023 Jul 1;35(4):334-346. doi: 10.1097/CCO.0000000000000956. Epub 2023 May 9. Curr Opin Oncol. 2023. PMID: 37222204

3

Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?

Audisio A, Fazio R, Hendlisz A, Sclafani F. Audisio A, et al. Among authors: hendlisz a. Curr Opin Oncol. 2023 Jul 1;35(4):315-317. doi: 10.1097/CCO.0000000000000945. Curr Opin Oncol. 2023. PMID: 37285030 No abstract available.

4

[No title available]

[No authors listed] [No authors listed] PMID: 36867176

5

New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspective.

Awada A, Mano M, Hendlisz A, Piccart M. Awada A, et al. Among authors: hendlisz a. Expert Rev Anticancer Ther. 2004 Feb;4(1):53-60. doi: 10.1586/14737140.4.1.53. Expert Rev Anticancer Ther. 2004. PMID: 14748657 Review.

6

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours.

Awada A, Hendlisz A, Gil T, Bartholomeus S, Mano M, de Valeriola D, Strumberg D, Brendel E, Haase CG, Schwartz B, Piccart M. Awada A, et al. Among authors: hendlisz a. Br J Cancer. 2005 May 23;92(10):1855-61. doi: 10.1038/sj.bjc.6602584. Br J Cancer. 2005. PMID: 15870716 Free PMC article. Clinical Trial.

7

Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer.

Personeni N, Hendlisz A, Gallez J, Galdon MG, Larsimont D, Van Laethem JL, Nagy N, Barette M, Paesmans M, Cardoso F, Bleiberg H. Personeni N, et al. Among authors: hendlisz a. Semin Oncol. 2005 Dec;32(6 Suppl 9):S59-62. doi: 10.1053/j.seminoncol.2005.04.029. Semin Oncol. 2005. PMID: 16399434

8

Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors.

Strumberg D, Clark JW, Awada A, Moore MJ, Richly H, Hendlisz A, Hirte HW, Eder JP, Lenz HJ, Schwartz B. Strumberg D, et al. Among authors: hendlisz a. Oncologist. 2007 Apr;12(4):426-37. doi: 10.1634/theoncologist.12-4-426. Oncologist. 2007. PMID: 17470685 Free article. Review.

9

Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres.

Van den Eynde M, Flamen P, El Nakadi I, Liberale G, Delatte P, Larsimont D, Hendlisz A. Van den Eynde M, et al. Among authors: hendlisz a. Clin Nucl Med. 2008 Oct;33(10):697-9. doi: 10.1097/RLU.0b013e318184b9a0. Clin Nucl Med. 2008. PMID: 18806572 No abstract available.

10

Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.

Flamen P, Vanderlinden B, Delatte P, Ghanem G, Ameye L, Van Den Eynde M, Hendlisz A. Flamen P, et al. Among authors: hendlisz a. Phys Med Biol. 2008 Nov 21;53(22):6591-603. doi: 10.1088/0031-9155/53/22/019. Epub 2008 Oct 31. Phys Med Biol. 2008. PMID: 18978442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page